Ion Financial Statements From 2010 to 2026
| IOBCF Stock | USD 15.26 0.51 3.46% |
Check Ion Beam financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ion Beam's main balance sheet or income statement drivers, such as , as well as many indicators such as . Ion financial statements analysis is a perfect complement when working with Ion Beam Valuation or Volatility modules.
Ion |
Ion Beam Applications Company Profit Margin Analysis
Ion Beam's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Ion Beam Profit Margin | 0.01 % |
Most of Ion Beam's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ion Beam Applications is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Ion Beam Applications has a Profit Margin of 0.0122%. This is 100.11% lower than that of the Healthcare sector and 100.22% lower than that of the Medical Devices industry. The profit margin for all United States stocks is 100.96% lower than that of the firm.
Ion Beam Applications Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ion Beam's current stock value. Our valuation model uses many indicators to compare Ion Beam value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ion Beam competition to find correlations between indicators driving Ion Beam's intrinsic value. More Info.Ion Beam Applications is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.55 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ion Beam Applications is roughly 1.81 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ion Beam's earnings, one of the primary drivers of an investment's value.About Ion Beam Financial Statements
Ion Beam stakeholders use historical fundamental indicators, such as Ion Beam's revenue or net income, to determine how well the company is positioned to perform in the future. Although Ion Beam investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ion Beam's assets and liabilities are reflected in the revenues and expenses on Ion Beam's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ion Beam Applications. Please read more on our technical analysis and fundamental analysis pages.
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium. ION Beam operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 1668 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Ion Pink Sheet
Ion Beam financial ratios help investors to determine whether Ion Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ion with respect to the benefits of owning Ion Beam security.